Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 20 studies | 43% ± 16% | |
| lung | 18 studies | 53% ± 14% | |
| intestine | 13 studies | 43% ± 17% | |
| kidney | 9 studies | 46% ± 15% | |
| eye | 9 studies | 49% ± 21% | |
| brain | 9 studies | 33% ± 9% | |
| lymph node | 7 studies | 52% ± 13% | |
| liver | 7 studies | 49% ± 18% | |
| bone marrow | 6 studies | 48% ± 21% | |
| uterus | 6 studies | 56% ± 13% | |
| pancreas | 4 studies | 57% ± 22% | |
| placenta | 4 studies | 57% ± 15% | |
| prostate | 4 studies | 57% ± 11% | |
| breast | 4 studies | 66% ± 7% | |
| ovary | 3 studies | 58% ± 5% | |
| adrenal gland | 3 studies | 51% ± 13% | |
| esophagus | 3 studies | 47% ± 6% | |
| skin | 3 studies | 66% ± 7% | |
| thymus | 3 studies | 75% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6075.91 | 1445 / 1445 | 100% | 162.02 | 183 / 183 |
| skin | 100% | 7777.26 | 1809 / 1809 | 100% | 402.18 | 472 / 472 |
| uterus | 100% | 5117.31 | 170 / 170 | 100% | 399.23 | 459 / 459 |
| bladder | 100% | 6140.00 | 21 / 21 | 100% | 283.99 | 503 / 504 |
| ovary | 100% | 4681.18 | 180 / 180 | 100% | 148.97 | 428 / 430 |
| lung | 100% | 5486.77 | 576 / 578 | 100% | 216.31 | 1152 / 1155 |
| stomach | 100% | 4636.78 | 359 / 359 | 99% | 204.49 | 284 / 286 |
| intestine | 100% | 6610.70 | 966 / 966 | 99% | 256.35 | 522 / 527 |
| breast | 100% | 3796.29 | 459 / 459 | 99% | 233.79 | 1107 / 1118 |
| brain | 99% | 4228.21 | 2613 / 2642 | 100% | 155.35 | 704 / 705 |
| prostate | 100% | 4976.05 | 244 / 245 | 99% | 114.23 | 496 / 502 |
| thymus | 100% | 3368.02 | 652 / 653 | 98% | 146.88 | 595 / 605 |
| adrenal gland | 100% | 3110.65 | 257 / 258 | 97% | 148.63 | 224 / 230 |
| pancreas | 97% | 1663.11 | 319 / 328 | 98% | 140.31 | 174 / 178 |
| kidney | 100% | 3815.58 | 89 / 89 | 95% | 92.11 | 856 / 901 |
| liver | 88% | 1590.46 | 199 / 226 | 83% | 97.15 | 339 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 208.48 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 405.41 | 29 / 29 |
| spleen | 100% | 6285.72 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 423.39 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 157.95 | 1 / 1 |
| blood vessel | 100% | 4766.47 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 3808.60 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 2608.64 | 791 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 8422.05 | 915 / 929 | 0% | 0 | 0 / 0 |
| heart | 96% | 2261.56 | 824 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006325 | Biological process | chromatin organization |
| GO_0071392 | Biological process | cellular response to estradiol stimulus |
| GO_0031507 | Biological process | heterochromatin formation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0001740 | Cellular component | Barr body |
| GO_0000792 | Cellular component | heterochromatin |
| GO_0000791 | Cellular component | euchromatin |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0000786 | Cellular component | nucleosome |
| GO_0005634 | Cellular component | nucleus |
| GO_0030527 | Molecular function | structural constituent of chromatin |
| GO_0000979 | Molecular function | RNA polymerase II core promoter sequence-specific DNA binding |
| GO_0031490 | Molecular function | chromatin DNA binding |
| GO_0031492 | Molecular function | nucleosomal DNA binding |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | H2AZ1 |
| Protein name | Histone H2A.Z (H2A/z) Histone H2A |
| Synonyms | H2AFZ H2AZ |
| Description | FUNCTION: Variant histone H2A which replaces conventional H2A in a subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. May be involved in the formation of constitutive heterochromatin. May be required for chromosome segregation during cell division. . |
| Accessions | ENST00000651623.1 A0A494C189 P0C0S5 ENST00000296417.6 |